Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

The Development of New Radiohalagenated Cocaine Analogues for Inviva Duty of Dopamine Reuptdae in New Radegenative Diseases

Technical Report ·
OSTI ID:430943

Fluorine-18-labeled 2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)-8-(3-fluoropropyl)nortropane (FPCT) has been synthesized as a new dopamine transporter imaging agent. Fluorine-18 was introduced into 2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)-8-[-3-fluoropropy] nortropane by preparation of 1-[{sup 18}F]fluoro-3-iodopropane followed by alkylation of 2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)nortropane. Tissue distribution studies in rats with [{sup 18}F]FPCT showed high striatal uptake (0.70% dose/g at 60 min; 0.38% dose/g at 120 min) and good striatal-to-cerebellum ratios (5.5 at 60 min; 6.2 at 120 min). Imaging studies in rhesus monkeys (n = 2) with [{sup 18}F]FPCT showed high uptake and retention in the putamen (P) (P = 0.03%-0.12% dose/g; at 115 min) and good putamen-to-cerebellum ratios of 3.40-3.43 at 115 min. Plasma metabolites were analyzed in rhesus monkeys (n = 2) by ether extraction and HLPC. The radioactivity in the ether-extractable fraction displayed a single peak that corresponded on HPLC to unmetabolized authentic FPCT. These results suggest that [{sup 18}F]FPCT is an excellent candidate for PET imaging of dopamine transporters. 32 refs., 7 figs., 3 tabs.

Research Organization:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN
Sponsoring Organization:
USDOE
DOE Contract Number:
FG05-93ER61737
OSTI ID:
430943
Report Number(s):
DOE/ER/61737; 93080402
Country of Publication:
United States
Language:
English